share_log

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(29.1%),Rosemina Merchant(29.1%), etc.

SEC ·  Feb 22, 2024 02:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more